Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: Prothena Corporation plc, 3 years.
Prothena Corporation plc
Director
Aktis Oncology Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Prothena Corporation plc May 16, 202399.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 12, 2026 | Aktis Oncology Inc. | Derivative conversion | +4,859,370 | — | — |
| Jan 12, 2026 | Aktis Oncology Inc. | Open-market purchase | +812,455 | $18.00 | $14,624,190 |
| Jan 12, 2026 | Aktis Oncology Inc. | Derivative conversion | +134,842 | — | — |
| Jan 12, 2026 | Aktis Oncology Inc. | Open-market purchase | +22,545 | $18.00 | $405,810 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.